Skip to main navigation
close search window
Cingulate Therapeutics LogoCingulate Therapeutics Logo
Connect With Us
Header Menu
  • Company
    • About Cingulate®
    • Senior Management
    • Board of Directors
    • Scientific Advisors
  • Patient Experience
    • Patient Experience
    • Treatments
  • Clinical Trials
    • Patient Recruitment
  • Pipeline
    • Pipeline Overview
    • Cingulate® Technology
    • CTx-1301
    • CTx-1302
    • Publications
  • Partners
  • Investors
    • Webcasts & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Press Releases
  • Cingulate In the News
Header Social TwitterLinkedIn
Header Menu
  • Company
    • About Cingulate®
    • Senior Management
    • Board of Directors
    • Scientific Advisors
  • Patient Experience
    • Patient Experience
    • Treatments
  • Clinical Trials
    • Patient Recruitment
  • Pipeline
    • Pipeline Overview
    • Cingulate® Technology
    • CTx-1301
    • CTx-1302
    • Publications
  • Partners
  • Investors
    • Webcasts & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • Press Releases
  • Cingulate In the News
back to top
close search window
Search:
search submit button
 

Event Details

23 Jun 2022 at 1:40 PM EDT Cingulate Presents at Diamond Equity Research 2022 Virtual Emerging Growth Invitational

Click here for webcast
CTx®_4C
TwitterLinkedIn

Contact us

1901 W 47th Place
Kansas City 66205

 

info@cingulate.com
913-942-2300

© Cingulate® |  PRIVACY POLICY